(Bloomberg) — Neurotrope Inc. plunged as much as 82%, falling below a dollar, after a placebo worked better than the company’s experimental treatment for Alzheimer’s disease.

More Failure of Alzheimer’s Disease Study Creates a New Penny Stock Videos